Beta Bionics, Inc. · NASDAQ:BBNX
Soleus Capital Management, L.P. reported a 8.80% stake in Beta Bionics, Inc. (Schedule 13G)
Event Mar 31, 2025 · Filed May 2, 2025
Soleus Capital Management, L.P. reported a 8.80% stake in Beta Bionics, Inc., 3,795,341 shares, as a passive investor on Mar 31, 2025. Filed May 2, 2025 (Schedule 13G).
- Stake
- 8.80%
- Shares
- 3,795,341
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 13 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Soleus BB SPV, LLC | 1.40% | 595,176 |
| Soleus Private Equity Fund I, L.P. | 0.90% | 396,204 |
| Soleus Private Equity GP I, LLC | 2.30% | 991,380 |
| Soleus PE GP I, LLC | 2.30% | 991,380 |
| Soleus Private Equity Fund II, L.P. | 3.90% | 1,703,961 |
| Soleus Private Equity GP II, LLC | 3.90% | 1,703,961 |
| Soleus PE GP II, LLC | 3.90% | 1,703,961 |
| Soleus Capital Master Fund, L.P. | 2.50% | 1,100,000 |
| Soleus Capital, LLC | 2.50% | 1,100,000 |
| Soleus Capital Group, LLC | 2.50% | 1,100,000 |
| Soleus Capital Management, L.P. | 8.80% | 3,795,341 |
| Soleus GP, LLC | 8.80% | 3,795,341 |
| Guy Levy | 8.80% | 3,795,341 |